Delivery Order SPE2DR25D3802-SPE2DR26F6UXF
- Not listed
- The Defense Logistics Agency awarded a $1,350.99 delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL 3mL insulin pens, with an ultimate completion date of September 18, 2025. This firm fixed-price, non-set-aside contract was awarded competitively on September 17, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania headquarters. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $1,163.64 delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL insulin pens (3mL units) with an ultimate completion date of November 19, 2025. This non-set-aside, firm fixed-price contract represents a competitively awarded delivery order issued under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical product will be performed and delivered from the contractor's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Lantus SoloStar 100 Unit/ML 3ML insulin pens, valued at $1,312.94. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of December 2, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement across...
- The Defense Logistics Agency awarded a $1,323.98 delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Lantus SoloStar 100 Unit/ml 3ml insulin pens. This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by December 2, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,770.53 for Lantus SoloStar 100 Unit/mL 3mL insulin pens on August 11, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by August 12, 2025. The products will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary operations facility. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,433.85 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 unit/mL insulin pens (3mL) on October 16, 2025, with an ultimate completion date of October 17, 2025. This competitively awarded, firm fixed-price contract includes no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $4,157.91 delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/ml 3ml insulin pens, with an ultimate completion date of October 29, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,310.67 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL 3mL insulin pens. This non-set-aside, competitively awarded contract operates under a firm fixed-price model with an ultimate completion date of December 2, 2025. The award was issued on December 1, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,635.29 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL 3mL insulin pens on August 18, 2025, with an ultimate completion date of August 19, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,022.80 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL insulin pens (3mL) on September 9, 2025, with completion expected by September 10, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor...
- SPE2DR25D3802Indefinite Delivery Contract
- SPE2DR25D3802-SPE2DR26F6UXFDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL insulin pens valued at $1,655.84 with a firm fixed price and ultimate completion date of December 9, 2025. This non-set-aside competitive award was issued on December 8, 2025, for delivery to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $999,999,999.00 comprehensive pharmaceutical support vehicle running through December 2026 that enables the company to supply medications, vaccines, medical devices, and specialized healthcare commodities globally to support military healthcare programs. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly for military and veteran healthcare systems, with an extensive portfolio of delivery orders covering diabetes medications, neurological treatments, pain management pharmaceuticals, antibiotics, and specialized medical supplies. The company's federal contract awards consistently demonstrate its capability to fulfill competitive procurement requirements across a broad spectrum of therapeutic domains, ranging from small-value transactions to substantial orders exceeding $45,000, serving customers including the Defense Health Agency and U.S. Coast Guard through flexible contract vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 12/7/25 |